We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Interatrial Shunt Helps Decompress Failing Heart

By HospiMedica International staff writers
Posted on 24 Oct 2019
Print article
Image: The Corvia InterAtrial Shunt Device (IASD) (Photo courtesy of Corvia Medical).
Image: The Corvia InterAtrial Shunt Device (IASD) (Photo courtesy of Corvia Medical).
A novel implantable cardiac shunt helps treat heart failure (HF) patients with preserved and mid-range ejection fraction.

The Corvia Medical (Tewksbury, MA, USA) Interatrial Shunt Device (IASD) is an innovative transcatheter implantable device designed to help diastolic HF function by forming a channel that connects left and right atria, thus facilitating continuous and dynamic decompression of the left atrium and enabling it to relax at rest and physical activity. Once in place, a permanent passage is created in the septum between the atria, resulting in reduction in HF symptoms, improved quality of life, and reduced hospitalization rates.

The IASD, which has been granted “Breakthrough Device” designation by the U.S. Food and Drug Administration (FDA), is being studied in the REDUCE LAP-HF II study, a large multi-national prospective, double-blind, sham-controlled trial randomizing 608 HFpEF and HFmrEF patients in the United States, European Union, Australia, Japan, and Canada. One-year follow-up data of the IASD clinical study, held in 64 patients implanted at 18 centers, demonstrated shunt patency for all participants who received the implant.

“Receiving Breakthrough Device designation from the FDA underscores the significant unmet need for more effective treatment options for heart failure patients,” said George Fazio, President and CEO of Corvia Medical. “We look forward to continuing our work with the FDA through our ongoing pivotal trial in more than 100 hospitals, and providing the clinical evidence which will accelerate the timeline to bring the IASD to the U.S. market.”

There are two types of HF; HF with reduced ejection fraction (HFrEF, systolic heart failure), and heart failure with preserved or mid‐range ejection fraction (HFpEF/HFmrEF), previously called diastolic heart failure. HFpEF accounts for approximately 50% of all HF, but treatment options are limited, consisting mainly of diuretics and fluid balance control. Although the pathophysiology of HFpEF is complex, many of the symptoms are a result of excessive rises in left atrial pressure, in particular during exercise.

Related Links:
Corvia Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Ultrasonic Cleaner
Cole-Parmer Ultrasonic Cleaner with Digital Timer
New
Anterior Cervical Plate System
XTEND

Print article

Channels

Surgical Techniques

view channel
Image: Synthetic images generated by each diffusion model contrasted with the corresponding real textural images of four types of polyps (Photo courtesy of UT at Austin)

AI-Assisted Imaging to Assist Endoscopists in Colonoscopy Procedures

Colorectal cancer is a major health concern in the United States, with the likelihood of developing the disease being 1 in 25 for women and 1 in 23 for men. Polyps, which are precursors to cancer, can... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.